Actelion Lauded for Support by European Pulmonary Hypertension Association

The European Organization for Rare Diseases awarded Actelion Pharmaceuticals the EURORDIS Company Award 2016, for their research and support of patients with Pulmonary Hypertension.

“I am very proud that, together with the PAH community, Actelion has brought about not one, but several paradigm shifts in PAH care.” -Martine Clozel, MD, chief scientific officer at Actelion.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email